Faculty Atlas
← All postings

Associate or Full Professor WOT (Program Head Phase I Clinical Trials) Medicine, Hematology, Oncology

University of Washington  ·  Seattle, WA
Associate ProfessorNon-TenureMedicine, Hematology, Oncology

Position summary

Associate or Full Professor WOT (Program Head Phase I Clinical Trials) Position Overview School / Campus / College: School of Medicine Organization: Medicine, Hematology, Oncology Title: Associate or Full Professor WOT (Program Head Phase I Clinical Trials) Position Details Position Description Associate Professor or Professor, CS, Phase I/Developmental Therapeutics Clinical Trials Program Head The Fred Hutchinson

Cancer Center (Fred Hutch) and the University of Washington (UW) invite nominations and applications to lead the Phase I Developmental Therapeutics clinical trials program. The position will be dual appointed with a primary faculty appointment in the Clinical Research Division at Fred Hutch and a secondary appointment in the UW Department of Medicine, Division of Hematology and Oncology. The position will report to

the Senior Vice President (SVP) of the Clinical Research Division at Fred Hutch and the Division Head of Hematology and Oncology at the UW. We seek a visionary leader to head our Phase I Developmental Therapeutics Program, focusing on innovative therapies to provide hope and healing to cancer patients. This Program Head will lead and oversee the development and execution of early-phase clinical trials for novel

cancer therapies. This role is crucial in translating groundbreaking research into clinical practice, ensuring the safe and efficient evaluation of new treatments. The successful candidate will partner with leaders of the Fred Hutch immunotherapy integrated research center and cell-based therapy team to develop and execute an institutional early phase trial strategy. The Program Head will foster strong collaborations

with translational researchers and clinical investigators at UW and Fred Hutch and will forge partnerships with biotech and pharmaceutical industry partners to grow the phase I program assets and advance our mission of delivering transformative cancer therapies to our patients. The Program Head’s overall responsibility will be to maintain and expand our Phase 1 clinical trials program in collaboration with our immune

therapy and cell-based therapy teams. Specific tasks will include (1) providing leadership in designing, implementing, and managing early-phase clinical trials; (2) working on a team to oversee appropriate selection and placement of phase I trials (3) coordinating the infrastructure needed for optimal implementation of phase I studies, including research nurses, data coordinators, regulatory affairs, tissue

Summary from the source posting. Always confirm details on the institution's official career page.